This post was originally published on this site
Original post: Newslookup FDA panel to vote on fast-track approval of ALS drug AMX0035
Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.